Welcome back to another edition of Endpoints Weekly. Two of the year’s major oncology conferences are coming up soon: AACR starting April 17, and ASCO
Following a judge’s ruling that suspended most of the Trump administration’s appointments to the CDC’s vaccine advisory panel, a newly published charter for the panel
The price differential between the US and other countries “will be significantly narrower or smaller” going forward because of pressure from the Trump administration’s “most
Five people with beta thalassemia who had their blood stem cells genetically altered no longer require regular blood transfusions to stay healthy. Their Chinese-made treatment
New China-US biotech gets $54M: Vivatides Therapeutics raised the Series A for its preclinical-stage R&D in siRNA and antisense oligonucleotides aimed at reaching tissues beyond
The FDA has once again rejected Replimune’s oncolytic virus therapy to treat advanced melanoma.
The Massachusetts-based drugmaker had been pushing for a reconsideration by the agency since the therapy was first rejected last July. At …
Copyright 2025 dijee Intelligence Ltd. dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844